USPTO serial 79032745
PHYNOVA
Reviewed by CopyMark Law Group
Reg. 3373284Status 404
- Filing date
- Status date
- Registration date
- Jan 22, 2008
- Examiner
- POVARCHUK, REBECCA JOYCE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PHYNOVA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Oxford Science Park; Oxford, GB
Oxford Science Park; Oxford, GB
Oxford Science Park; Oxford, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michelle L. Visser
Michelle L. Visser Rader, Fishman & Grauer PLLC39533 Woodward Avenue, Suite 140Bloomfield Hills, MI 48304UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, pharmaceutical products for the treatment of liver disease, fatty liver disease, liver disorders, respiratory disorders, cancer, metabolic disorders, obesity, post operative ileus and for wound healing; veterinary preparations, namely, pharmaceutical products for the treatment of liver disease, fatty liver disease, liver disorders, respiratory disorders, cancer, metabolic disorders, obesity, post operative ileus and for wound healing; virucides; bactericides; antibiotics; dietetic substances, namely, food adapted for medical use and food supplements for humans and animals; antiviral medicines namely medicines for use in treating hepatitis C and dengue fever; medicines for use in treating obesity; medicines for use in treating respiratory diseases including colds, flu, chronic bronchitis, respiratory syncytical virus, SARS and pneumonia; herbs for medicinal purposes, namely, plant extracts for medical, veterinary and pharmaceutical purposes; medicinal herb extracts; medicinal oils, namely, plant oils for medical, veterinary and pharmaceutical purposes; medicinal infusions, namely, plant extract infusions for medical, veterinary and pharmaceutical purposes; pure extracts of medicinal plants and herbs; herb teas for medicinal purposes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 28, 2018 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Sep 28, 2018 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 28, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 15, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 25, 2015 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 25, 2015 | INPC | INVALIDATION PROCESSED | — |
| Apr 29, 2015 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 29, 2014 | C71T | CANCELLED SECTION 71 | — |
| Jul 21, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 5, 2009 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 29, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 29, 2008 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 22, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 22, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 6, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 17, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 1, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 28, 2007 | ALIE | ASSIGNED TO LIE | — |
| Aug 28, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 24, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 23, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 23, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 23, 2007 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 23, 2007 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 15, 2007 | RFNP | REFUSAL PROCESSED BY IB | — |
| Feb 23, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 23, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 22, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 21, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 9, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 5, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Dec 28, 2006 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |